| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |